Stockreport

Your Daily Pharma Scoop: TGTX Positive Data In MS, Iovance Trial Delay [Seeking Alpha]

IMMUNE DESIGN CORP COMMON STOCK  (IMDZ) 
Last immune design corp common stock earnings: 11/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.immunedesign.com/investor-relations
PDF Summary TGTX showed positive phase 2 data in relapsing MS. After its initial hiccup earlier with its CLL drug, this news should bolster the stock a little. Iov [Read more]